Table 5.

Logistic regression results T2DM ESRD versus T2DM non-nephropathy controls—MYH9 haplotypes, age and gender adjusted

		Haplotype frequency		No admixture adjustment			Admixture adjustment
Haplotype	Model	Case	Control	P-value	OR	95% CI	P-value	OR	95% CI
E1 haplotype consisting of SNPs: rs4821480— rs2032487—rs4821481—rs3752462
3224	Dominant	0.63	0.58	0.6619	1.10	(0.73, 1.65)	0.9083	0.98	(0.64, 1.48)
	Additive			0.1081	1.19	(0.96, 1.48)	0.3213	1.12	(0.90, 1.39)
	Recessive			0.0479	1.38	(1.00, 1.89)	0.1308	1.28	(0.93, 1.77)
4442	Dominant	0.20	0.22	0.0991	0.77	(0.57, 1.05)	0.2606	0.84	(0.61, 1.14)
	Additive			0.4091	0.90	(0.69, 1.16)	0.8426	0.97	(0.74, 1.27)
	Recessive			0.1076	2.20	(0.84, 5.72)	0.0428	2.74	(1.03, 7.26)
4444	Dominant	0.13	0.18	0.0504	0.72	(0.51, 1.00)	0.0799	0.74	(0.53, 1.04)
	Additive			0.0232	0.72	(0.54, 0.96)	0.0425	0.74	(0.56, 0.99)
	Recessive			0.0702	0.45	(0.19, 1.07)	0.1083	0.49	(0.20, 1.17)
L1 haplotype consisting of SNPs: rs7078—rs12107—rs735853—rs5756129
1324	Dominant	0.63	0.59	0.2865	1.25	(0.83, 1.89)	0.4693	1.17	(0.77, 1.77)
	Additive			0.1681	1.17	(0.94, 1.45)	0.3361	1.12	(0.89, 1.39)
	Recessive			0.2390	1.21	(0.88, 1.66)	0.4055	1.15	(0.83, 1.57)
1334	Dominant	0.80	0.90	0.7211	0.93	(0.61, 1.40)	0.8550	1.04	(0.68, 1.59)
	Additive			0.9353	0.98	(0.67, 1.44)	0.6249	1.10	(0.75, 1.63)
	Recessive			0.3516	2.63	(0.34, 20.03)	0.2460	3.36	(0.43, 25.99)